office celebrated a milestone this year, returning for its tenth year of participation in the BreakthroughT1DReal EstateGames, an annual charity event that brings together construction companies, ...
... and dosing has begun in a Phase 2 clinical study (CTI-0602K-201A, NCT07186660) evaluating CIR-0602K in adults with type 1 diabetes (T1D) treating their T1D with automated insulin delivery (AID).
Kowalski, Ph.D., BreakthroughT1DCEO... About Type 1 Diabetes (T1D) T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all ... The onset of T1D has nothing to do with diet or lifestyle.
Canada's largest type 1 diabetes organization, formerly JDRF, urges federal partnership to establish a national network that would accelerate T1D cures and position Canada as a global hub for cell therapy clinical trials.
About Type 1 Diabetes (T1D) T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all ... The onset of T1D has nothing to do with diet or lifestyle ... There is currently no cure for T1D. .
Honored as BreakthroughT1D's Cincinnatian of the Year ... About Breakthrough T1D, Formerly JDRF ... About Type 1 Diabetes (T1D)T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all.
WESTDES MOINES, Iowa (May 5, 2026) - Today, Hy-Vee announced that its annual register round up for BreakthroughT1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, raised $290,661 for the nonprofit.